MétaCan
Menu
← Back to cohort

Can Engineering IL-2Rα Expression Improve NK Cell Immunotherapy?

2023· article· en· W4385687833 on OpenAlexaffabout
Seung-Hwan Lee, Bryan Marr, Donghyeon Jo, Scott McComb

Bibliographic record

VenueThe Journal of Immunology · 2023
Typearticle
Languageen
FieldMedicine
TopicCAR-T cell therapy research
Canadian institutionsNational Research Council CanadaUniversity of Ottawa
Fundersnot available
KeywordsChimeric antigen receptorImmunotherapyCancer immunotherapyInterleukin 21Interleukin 12Cancer researchLymphokine-activated killer cellImmunologyCell therapyAdoptive cell transferInterleukin 15CellJanus kinase 3BiologyT cellCell biologyCytotoxic T cellCytokineStem cellImmune systemIn vitroInterleukin

Abstract

fetched live from OpenAlex

Abstract Natural killer (NK) cells are innate lymphocytes central to anti-viral and anti-tumour responses. Activated NK cells upregulate IL-2Rα, promoting the formation of a high-affinity heterotrimeric IL-2Rαβγ that mediates NK cell expansion and enhances cytotoxicity. Several applications of NK cancer immunotherapy, including using chimeric antigen receptors (CAR), have shown early success in clinical studies. Allogeneic NK cells can illicit anti-tumour activity without toxicities, making them attractive for a biomanufactured “off-the-shelf” immunotherapy. Following adoptive transfer, low-dose IL-2 injections are commonly administered to enhance NK cell activity. However, expansion, persistence, and tumour clearance remain largely inadequate. Moreover, regulatory T cells (Tregs) can use their IL-2Rα expression to sequester injected IL-2, leading to Treg expansion and NK cell suppression. We hypothesize that CAR NK cell therapy can be improved by engineering high expression of IL-2Rα alongside the CAR. We predict the resulting CAR-IL2Rα NK cells will be more sensitive to low-dose IL-2 injections. We used lentiviral transduction of a multicistronic transgene to force high IL-2Rα expression alongside a CAR. I found CAR-IL2Rα NK cells were more responsive to low-dose IL-2 in-vitro than conventional CAR NK cells. This novel strategy may improve clinical success by enhancing CAR NK cell expansion, persistence and anti-tumour activity, and limiting Treg suppression in the tumour microenvironment. NRC Disruptive Technology Solutions Cell and Gene Therapy Challenge Program and the Canadian Institutes of Health Research

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.000
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Bench or experimental · Consensus signal: Bench or experimental
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.001
Threshold uncertainty score0.005

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0000.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0010.001
Open science0.0000.000
Research integrity0.0010.001
Insufficient payload (model declined to judge)0.0010.001

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.015
GPT teacher head0.275
Teacher spread0.261 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designBench or experimental
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2023
Admission routes2
Has abstractyes

Explore more

Same venueThe Journal of Immunology→Same topicCAR-T cell therapy research→French-language works237,207→